Strengths and challenges to phage biocontrol

Because of the self-replicating nature of phages, they may only need to be applied once which may result in a cheaper dose application cost than chemotherapeutants (Sulakvelidze et al., 2001). While there is potential for 

Neutralizing anti-phage antibodies have been reported in phage therapy trials in humans (Kucharewicz-Krukowska Slopek, 1987) and animals 

---